Skip to main content

Table 1 Correlation of TP53TG1 expression with clinicopathological features of no-small cell lung cancer patients

From: TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis

Characteristics

Group

Total (n = 40)

TP53TG1 expression

P value

High (n = 20)

Low (n = 20)

Gender

Male

19

11

8

0.342

Female

21

9

12

 

Age (years)

< 60

23

10

13

0.337

≥ 60

17

10

7

 

Lymph node metastasis

Yes

19

9

10

0.752

No

21

11

10

 

Smoking

Yes

18

8

10

0.525

No

22

12

10

 

Stage (TNM)

I, II

19

14

5

0.004*

III, IV

21

6

15

 
  1. P < 0.05 was considered significantly significant